Fatal familial insomnia: Clinical features and early identification

Annals of Neurology

Volumn 63, Issue 5, 2008, Pages 658-661

  Krasnianski, Anna ^a   Bartl, Mario ^a   Sanchez Juan, Pascual J ^b,c   Heinemann, Uta ^a   Meissner, Bettina ^a   Varges, Daniela ^a   Schulze Sturm, Ulf ^a   Kretzschmar, Haus A ^d   Schulz Schaeffer, Walter J ^a   Zerr, Inga ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOFETAMINE I 123; PROTEIN 14 3 3;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; ELECTROENCEPHALOGRAPHY; FATAL FAMILIAL INSOMNIA; FEMALE; GENOTYPE; HUMAN; MALE; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PRION; PROGNOSIS;

14-3-3 PROTEINS; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSOMNIA, FATAL FAMILIAL; MALE; MIDDLE AGED; PRIONS; PROGNOSIS;

EID: 44849142719     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21358     Document Type: Article

References (20)

1. Lugaresi E, Medori R, Montagna P, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med 1986;315:997-1003.
2. Zarranz JJ, Digon A, Atares B, et al. Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry 2005;76:1491-1496.
3. Harder A, Gregor A, Wirth T, et al. Early age of onset in fatal familial insomnia. Two novel cases and review of the literature. J Neurol 2004;251:715-724.
4. McLean CA, Storey E, Gardner RJ, et al. The D178N-129M "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology 1997;49:552-558.
5. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999;46:224-233.
6. Montagna P, Cortelli P, Avoni P, et al. Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene. Brain Pathol 1998;8:515-520.
7. Gambetti P, Petersen R, Monari L, et al. Fatal familial insomnia and the widening spectrum of prion diseases. Br Med Bull 1993;49:980-994.
8. American Academy of Sleep Medicine. Fatal familial insomnia (337.9). The international classification of sleep disorders, revised: diagnostic and coding manual. Chicago, IL: American Academy of Sleep Medicine, 2001:245-247.
9. Cortelli P, Perani D, Montagna P, et al. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain 2006;129:668-675.
10. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol 1998;43:32-40.
11. Krasnianski A, Schulz-Schaeffer WJ, Kallenberg K, et al. Clinical findings and diagnostic tests in the MV-2 subtype of sporadic CJD. Brain 2006;129:2288-2296.
12. Sforza E, Montagna P, Tinuper P, et al. Sleep-wake cycle abnormalities in fatal familial insomnia. Evidence of the role of the thalamus in sleep regulation. Electroencephalogr Clin Neurophysiol 1995;94:398-405.
13. Matsuda M, Tabata K, Hattori T, et al. Brain SPECT with 123I-IMP for the early diagnosis of Creutzfeldt-Jakob disease. J Neurol Sci 2001;183:5-12.
14. Manetto V, Medori R, Cortelli P, et al. Fatal familial insomnia: clinical and pathologic study of five new cases. Neurology 1992;42:312-319.
15. Pocchiari M, Poupolo M, Croes EA, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 2004;10:2348-2359.
16. Harder A, Jendroska K, Kreuz F, et al. Novel twelve-generation kindred of fatal familial insomnia from Germany representing the entire spectrum of disease expression. Am J Med Genet 1999;87:311-316.
17. Gambetti P, Parchi P, Petersen RB, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathol 1995;5:43-51.
18. Krasnianski A, Meissner B, Schulz-Schaeffer W, et al. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease. Arch Neurol 2006;63:876-880.
19. Mastrianni JA, Nixon R, Layzer R, et al. Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 1999;340:1630-1638.
20. Goldfarb LG, Petersen RB, Tabaton M, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 1992;258:806-808.